Brucellosis Vaccines Market 2028 By Product, Application, End User and Geography | The Insight Partners

report image

Brucellosis Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (DNA Vaccines, Subunit Vaccines, Vector Vaccines, B. Abortus Recombinant Mutants, Others); Application (Cattle, Sheep, Pigs, Others); End User (Veterinary Hospitals, Veterinary Clinics, Animal Care Centers) and Geography

Report Code: TIPRE00008665 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Brucellosis is a notably transmissible zoonotic infection. Bacterial genus Brucella is accountable for the disease. Brucella is transported from animals to people by consumption of infected undercooked meat, foodstuff, or unpasteurized milk from infected animals. Immediate contact with an infected animal or their releases; or breathing of aerosols.


The brucellosis vaccines market is projected to grow in the forecast period owing to technological innovations, rising awareness about animal health. Moreover, the increasing funding by government organizations and associations, upsurge in demand for fish, milk, eggs, and animal protein and increased expenditure on health care of companion animals are also offering opportunities in market growth during the forecast period.


The "Global Brucellosis Vaccines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Brucellosis vaccines market with detailed market segmentation by product, application, end user and geography. The global brucellosis vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Brucellosis vaccines market players and offers key trends and opportunities in the market.


The global brucellosis vaccines market is segmented on the basis of product, application, and end user. Based on type, the market is segmented into DNA vaccines, subunit vaccines, vector vaccines, B. abortus recombinant mutants, and others. Based on application, the brucellosis vaccines market is segmented into cattle, sheep, pigs, and others. Based on end user, the brucellosis vaccines market is segmented into veterinary hospitals, veterinary clinics, and animal care centers.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Brucellosis vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Brucellosis vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting brucellosis vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Brucellosis vaccines market in these regions.

Get more information on this report :


The report covers key developments in the brucellosis vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from brucellosis vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for Brucellosis vaccines in the global market. Below mentioned is the list of few companies engaged in the Brucellosis vaccines market.

The report also includes the profiles of key brucellosis vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Boehringer Ingelheim
- Merck Animal Health
- Bayer AG
- Ceva
- Zoetis
- Biogénesis Bago
- Indian Immunologicals Limited
- Elanco (Lohmann Animal Health)
- Heska Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Boehringer Ingelheim
2. Merck Animal Health
3. Bayer AG
4. Ceva
6. Zoetis
7. Biogénesis Bago
8. Indian Immunologicals Limited
9. Elanco (Lohmann Animal Health)
10. Heska Corporation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount